z-logo
open-access-imgOpen Access
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
Author(s) -
Anthony M. Battram,
Aina OliverCaldés,
María SuárezLledó,
Miquel Lozano,
Miquel Bosch i Crespo,
Núria MartínezCibrián,
Joan Cid,
David F. Moreno,
Luis Gerardo RodríguezLobato,
Álvaro UrbanoIspizua,
Carlos Fernández de Larrea
Publication year - 2022
Publication title -
molecular therapy — methods and clinical development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.285
H-Index - 32
ISSN - 2329-0501
DOI - 10.1016/j.omtm.2022.06.010
Subject(s) - chimeric antigen receptor , progenitor cell , multiple myeloma , t cell , apheresis , cancer research , immunotherapy , antigen , immunology , stem cell , medicine , biology , immune system , microbiology and biotechnology , platelet

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom